ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II (2022)
Malmegrim, Kelen Cristina Ribeiro ; Toubert, A.; Farge, D.; Rodrigues, Maria Carolina de Oliveira
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, Kelen Cristina Ribeiro et al. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2022.1038338. Acesso em: 11 jun. 2024. , 2022
APA
Malmegrim, K. C. R., Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2022). Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2022.1038338
NLM
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Vancouver
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Artigo de periodico
Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy (2022)
Silva, Maria Cláudia da; Fuzo, Carlos Alessandro ; Paiva, Isadora Marques ; Bibo, Naira Lopes; Oliveira, Maykon Tavares de; Soares, Hellen Anastácia da Silva; Chevillard, Christophe; Kalil Filho, Jorge Elias ; Cunha Neto, Edecio ; Cunha, Thiago Mattar ; Silva, João Santana da
Fonte: Immunobiology. Unidades: FM, FMRP, FCFRP
Assuntos: MUTAÇÃO, DOENÇA DE CHAGAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Maria Cláudia da et al. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy. Immunobiology, v. 227, n. 5, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.imbio.2022.152242. Acesso em: 11 jun. 2024.
APA
Silva, M. C. da, Fuzo, C. A., Paiva, I. M., Bibo, N. L., Oliveira, M. T. de, Soares, H. A. da S., et al. (2022). Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy. Immunobiology, 227( 5), 1-7. doi:10.1016/j.imbio.2022.152242
NLM
Silva MC da, Fuzo CA, Paiva IM, Bibo NL, Oliveira MT de, Soares HA da S, Chevillard C, Kalil Filho JE, Cunha Neto E, Cunha TM, Silva JS da. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy [Internet]. Immunobiology. 2022 ; 227( 5): 1-7.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.imbio.2022.152242
Vancouver
Silva MC da, Fuzo CA, Paiva IM, Bibo NL, Oliveira MT de, Soares HA da S, Chevillard C, Kalil Filho JE, Cunha Neto E, Cunha TM, Silva JS da. Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients with chronic Chagas cardiomyopathy [Internet]. Immunobiology. 2022 ; 227( 5): 1-7.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.imbio.2022.152242
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Fonte: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Assuntos: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 11 jun. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Sepsis expands a CD39 + plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity (2021)
Nascimento, Daniele Carvalho ; Viacava, Paula Ramos; Ferreira, Raphael Gomes; Damaceno, Marina Alves; Piñeros, Annie Rocío Alvarez ; Melo, Paulo Henrique de; Donate, Paula Barbim ; Toller-Kawahisa, Juliana Escher; Zoppi, Daniel ; Veras, Flávio Protásio ; Peres, Raphael S. ; Silva, Luisa Menezes ; Caetité, Diego ; Oliveira, Antonio Edson Rocha; Castro, Icaro Maia Santos ; Kauffenstein, Gilles ; Nakaya, Helder Takashi Imoto ; Borges, Marcos de Carvalho ; Zamboni, Dario Simões ; Fonseca, Denise Morais da ; Paschoal, Jonas Augusto Rizzato ; Cunha, Thiago Mattar ; Quesniaux, Valerie ; Linden, Joel ; Cunha, Fernando Queiróz ; Ryffe, Bernhard; Alves-Filho, José Carlos
Fonte: Immunity. Unidades: FMRP, FCFRP, FCF, ICB, BIOINFORMÁTICA
Assuntos: ADENOSINA, FÁRMACOS IMUNOSSUPRESSORES, SEPSE, CAMUNDONGOS, INTERLEUCINA 10, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Daniele Carvalho et al. Sepsis expands a CD39 + plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity. Immunity, v. 54, n. 9, p. 2024-2041, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.immuni.2021.08.005. Acesso em: 11 jun. 2024.
APA
Nascimento, D. C., Viacava, P. R., Ferreira, R. G., Damaceno, M. A., Piñeros, A. R. A., Melo, P. H. de, et al. (2021). Sepsis expands a CD39 + plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity. Immunity, 54( 9), 2024-2041. doi:10.1016/j.immuni.2021.08.005
NLM
Nascimento DC, Viacava PR, Ferreira RG, Damaceno MA, Piñeros ARA, Melo PH de, Donate PB, Toller-Kawahisa JE, Zoppi D, Veras FP, Peres RS, Silva LM, Caetité D, Oliveira AER, Castro IMS, Kauffenstein G, Nakaya HTI, Borges M de C, Zamboni DS, Fonseca DM da, Paschoal JAR, Cunha TM, Quesniaux V, Linden J, Cunha FQ, Ryffe B, Alves-Filho JC. Sepsis expands a CD39 + plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity [Internet]. Immunity. 2021 ; 54( 9): 2024-2041.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.immuni.2021.08.005
Vancouver
Nascimento DC, Viacava PR, Ferreira RG, Damaceno MA, Piñeros ARA, Melo PH de, Donate PB, Toller-Kawahisa JE, Zoppi D, Veras FP, Peres RS, Silva LM, Caetité D, Oliveira AER, Castro IMS, Kauffenstein G, Nakaya HTI, Borges M de C, Zamboni DS, Fonseca DM da, Paschoal JAR, Cunha TM, Quesniaux V, Linden J, Cunha FQ, Ryffe B, Alves-Filho JC. Sepsis expands a CD39 + plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity [Internet]. Immunity. 2021 ; 54( 9): 2024-2041.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.immuni.2021.08.005
Artigo de periodico
DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells (2021)
Yau, Helen Loo ; Bell, Emma ; Ettayebi, Ilias ; Almeida, Felipe Campos de ; Boukhaled, Giselle M.; Shen, Shu Yi ; Allard, David; Morancho, Beatriz ; Marhon, Sajid A. ; Ishak, Charles A. ; Gonzaga, Isabela M. ; Medina, Tiago da Silva ; Singhania, Rajat; Chakravarthy, Ankur; Chen, Raymond; Mehdipour, Parinaz ; Pommey, Sandra; Klein, Christian ; Amarante-Mendes, João Gustavo Pessini ; Roulois, David ; Arribas, Joaquín ; Stagg, John ; Brooks, David G.; Carvalho, Daniel D. de
Fonte: Molecular Cell. Unidades: ICB, FCFRP
Assuntos: IMUNOLOGIA, LINFÓCITOS T, CÉLULAS MORTAS, APOPTOSE, CITOTOXICIDADE IMUNOLÓGICA, IMUNOGENÉTICA, CÉLULAS CULTIVADAS DE TUMOR, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAU, Helen Loo et al. DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells. Molecular Cell, v. 81, n. 7, p. 1469-1483, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.molcel.2021.01.038. Acesso em: 11 jun. 2024.
APA
Yau, H. L., Bell, E., Ettayebi, I., Almeida, F. C. de, Boukhaled, G. M., Shen, S. Y., et al. (2021). DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells. Molecular Cell, 81( 7), 1469-1483. doi:10.1016/j.molcel.2021.01.038
NLM
Yau HL, Bell E, Ettayebi I, Almeida FC de, Boukhaled GM, Shen SY, Allard D, Morancho B, Marhon SA, Ishak CA, Gonzaga IM, Medina T da S, Singhania R, Chakravarthy A, Chen R, Mehdipour P, Pommey S, Klein C, Amarante-Mendes JGP, Roulois D, Arribas J, Stagg J, Brooks DG, Carvalho DD de. DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells [Internet]. Molecular Cell. 2021 ; 81( 7): 1469-1483.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.molcel.2021.01.038
Vancouver
Yau HL, Bell E, Ettayebi I, Almeida FC de, Boukhaled GM, Shen SY, Allard D, Morancho B, Marhon SA, Ishak CA, Gonzaga IM, Medina T da S, Singhania R, Chakravarthy A, Chen R, Mehdipour P, Pommey S, Klein C, Amarante-Mendes JGP, Roulois D, Arribas J, Stagg J, Brooks DG, Carvalho DD de. DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells [Internet]. Molecular Cell. 2021 ; 81( 7): 1469-1483.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.molcel.2021.01.038
Artigo de periodico
Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study (2021)
Maia-Campos, Patrícia Maria Berardo G ; Franco, Rodolfo Scarpino Barboza; Kakuda, Letícia; Cadioli, Gabriel Fernandes; Costa, Gabriela Maria D'angelo ; Bouvret, Elodie
Fonte: Molecules. Unidade: FCFRP
Assuntos: PELE, ENVELHECIMENTO, COSMÉTICOS, COLÁGENO, SUPLEMENTOS DIETÉTICOS, MORFOLOGIA (ANATOMIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIA-CAMPOS, Patrícia Maria Berardo G et al. Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study. Molecules, v. 26, n. 16, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26164880. Acesso em: 11 jun. 2024.
APA
Maia-Campos, P. M. B. G., Franco, R. S. B., Kakuda, L., Cadioli, G. F., Costa, G. M. D. 'angelo, & Bouvret, E. (2021). Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study. Molecules, 26( 16), 1-15. doi:10.3390/molecules26164880
NLM
Maia-Campos PMBG, Franco RSB, Kakuda L, Cadioli GF, Costa GMD'angelo, Bouvret E. Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study [Internet]. Molecules. 2021 ; 26( 16): 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3390/molecules26164880
Vancouver
Maia-Campos PMBG, Franco RSB, Kakuda L, Cadioli GF, Costa GMD'angelo, Bouvret E. Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study [Internet]. Molecules. 2021 ; 26( 16): 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3390/molecules26164880
Artigo de periodico
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN (2020)
Benlabiod, Camélia; Cacemiro, Maira da Costa ; Nédélec, Audrey; Edmond, Valérie; Muller, Delphine; Rameau, Philippe; Touchard, Laure; Gonin, Patrick; Constantinescu, Stefan N.; Raslova, Hana; Villeval, Jean-Luc; Vainchenker, William; Plo, Isabelle; Marty, Caroline
Fonte: Nature Communications. Unidade: FCFRP
Assuntos: ANIMAIS, MODELOS ANIMAIS, CÉLULAS-TRONCO, MUTAGÊNESE, RATOS, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENLABIOD, Camélia et al. Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN. Nature Communications, v. 11, n. 1, p. 1-15, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41467-020-18691-3. Acesso em: 11 jun. 2024.
APA
Benlabiod, C., Cacemiro, M. da C., Nédélec, A., Edmond, V., Muller, D., Rameau, P., et al. (2020). Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN. Nature Communications, 11( 1), 1-15. doi:10.1038/s41467-020-18691-3
NLM
Benlabiod C, Cacemiro M da C, Nédélec A, Edmond V, Muller D, Rameau P, Touchard L, Gonin P, Constantinescu SN, Raslova H, Villeval J-L, Vainchenker W, Plo I, Marty C. Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN [Internet]. Nature Communications. 2020 ; 11( 1): 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1038/s41467-020-18691-3
Vancouver
Benlabiod C, Cacemiro M da C, Nédélec A, Edmond V, Muller D, Rameau P, Touchard L, Gonin P, Constantinescu SN, Raslova H, Villeval J-L, Vainchenker W, Plo I, Marty C. Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN [Internet]. Nature Communications. 2020 ; 11( 1): 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1038/s41467-020-18691-3
Artigo de periodico
Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers (2020)
Gonzalez Gil, Liseth Viviana; Singh, Harminder; Silva, Juliana de Sá da; Santos, Diogo Peres dos; Covas, Dimas Tadeu ; Swiech, Kamilla ; Torres Suazo, Claudio Alberto
Fonte: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS ESTROMAIS, ENGENHARIA QUÍMICA, MEDICINA REGENERATIVA, REATORES BIOQUÍMICOS, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZALEZ GIL, Liseth Viviana et al. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, v. 162, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2020.107710. Acesso em: 11 jun. 2024.
APA
Gonzalez Gil, L. V., Singh, H., Silva, J. de S. da, Santos, D. P. dos, Covas, D. T., Swiech, K., & Torres Suazo, C. A. (2020). Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, 162, 1-11. doi:10.1016/j.bej.2020.107710
NLM
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Vancouver
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Artigo de periodico-carta/editorial
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2019.03044. Acesso em: 11 jun. 2024. , 2020
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2019.03044
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Artigo de periodico
Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease (2020)
Tozatto-Maio, Karina; Girot, Robert; Ly, Indou Deme ; Silva-Pinto, Ana Cristina; Rocha, Vanderson Geraldo ; Fernandes, Francisco José de Almeida; Diagne, Ibrahima; Benzerara, Yahia ; Dinardo, Carla Luana ; Soler, Júlia Maria Pavan ; Haddad, Simone Kashima ; Araujo, Itauá Leston ; Kenzey, Chantal ; Fonseca, Guilherme Henrique Hencklain; Sandoval, Evandra Strazza Rodrigues ; Volt, Fernanda; Jarduli, Luciana; Ruggeri, Annalisa ; Mariaselvam, Christina ; Gualandro, Sandra Fátima Menosi ; Rafii, Hanadi ; Cappelli, Barbara ; Nogueira, Felipe Melo; Scigliuolo, Graziana Maria; Cunha, Renato Luiz Guerino ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Simões, Belinda Pinto ; Gluckman, Eliane ; Tamouza, Ryad
Fonte: Frontiers in Immunology. Unidades: FMRP, FM, FCFRP, IME
Assuntos: ANEMIA FALCIFORME, REGRESSÃO LOGÍSTICA, R (SOFTWARE ESTATÍSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO-MAIO, Karina et al. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.02041. Acesso em: 11 jun. 2024.
APA
Tozatto-Maio, K., Girot, R., Ly, I. D., Silva-Pinto, A. C., Rocha, V. G., Fernandes, F. J. de A., et al. (2020). Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.02041
NLM
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Vancouver
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Artigo de periodico
Molecular basis of carrageenan-induced cytokines production in macrophages (2020)
Lopes, Alexandre Hashimoto Pereira; Silva, Rangel Leal; Fonseca, Miriam das Dores Mendes; Gomes, Francisco Isaac Fernandes; Maganin, Alexandre Gomes de Macedo; Ribeiro, Lucas S.; Marques, Lucas Maciel Mauriz; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Zamboni, Dario Simões; Lopes, Norberto Peporine ; Franklin, Bernardo S.; Gombault, Aurélie; Ramalho, Fernando Silva ; Quesniaux, Valérie F. J.; Couillin, Isabelle; Ryffel, Bernhard; Cunha, Thiago Mattar
Fonte: Cell Communication and Signaling. Unidades: FCFRP, FMRP
Assuntos: CARRAGENINA, MACRÓFAGOS, POLISSACARÍDEOS, CITOCINAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Alexandre Hashimoto Pereira et al. Molecular basis of carrageenan-induced cytokines production in macrophages. Cell Communication and Signaling, v. 18, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12964-020-00621-x. Acesso em: 11 jun. 2024.
APA
Lopes, A. H. P., Silva, R. L., Fonseca, M. das D. M., Gomes, F. I. F., Maganin, A. G. de M., Ribeiro, L. S., et al. (2020). Molecular basis of carrageenan-induced cytokines production in macrophages. Cell Communication and Signaling, 18( 1). doi:10.1186/s12964-020-00621-x
NLM
Lopes AHP, Silva RL, Fonseca M das DM, Gomes FIF, Maganin AG de M, Ribeiro LS, Marques LMM, Cunha F de Q, Alves Filho JCF, Zamboni DS, Lopes NP, Franklin BS, Gombault A, Ramalho FS, Quesniaux VFJ, Couillin I, Ryffel B, Cunha TM. Molecular basis of carrageenan-induced cytokines production in macrophages [Internet]. Cell Communication and Signaling. 2020 ; 18( 1):[citado 2024 jun. 11 ] Available from: https://doi.org/10.1186/s12964-020-00621-x
Vancouver
Lopes AHP, Silva RL, Fonseca M das DM, Gomes FIF, Maganin AG de M, Ribeiro LS, Marques LMM, Cunha F de Q, Alves Filho JCF, Zamboni DS, Lopes NP, Franklin BS, Gombault A, Ramalho FS, Quesniaux VFJ, Couillin I, Ryffel B, Cunha TM. Molecular basis of carrageenan-induced cytokines production in macrophages [Internet]. Cell Communication and Signaling. 2020 ; 18( 1):[citado 2024 jun. 11 ] Available from: https://doi.org/10.1186/s12964-020-00621-x
Artigo de periodico
Egg white hydrolysate prevents reproductive impairments induced by cadmium in rats (2020)
Pinheiro, José Eudes Gomes; Martinez, Caroline Silveira; Moraes, Paola Zambelli; Stasiaki, José Eduardo; Trost, Maria Elisa; Vassallo, Dalton Valentim; Barbosa Junior, Fernando ; Peçanha, Franck Maciel; Cibin, Francielli Weber Santos; Miguel, Marta; Wiggers, Giulia Alessandra
Fonte: Journal of Functional Foods. Unidade: FCFRP
Assuntos: SISTEMA UROGENITAL, HIDRÓLISE, ANTIOXIDANTES, CÁDMIO, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, José Eudes Gomes et al. Egg white hydrolysate prevents reproductive impairments induced by cadmium in rats. Journal of Functional Foods, v. 67, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jff.2020.103823. Acesso em: 11 jun. 2024.
APA
Pinheiro, J. E. G., Martinez, C. S., Moraes, P. Z., Stasiaki, J. E., Trost, M. E., Vassallo, D. V., et al. (2020). Egg white hydrolysate prevents reproductive impairments induced by cadmium in rats. Journal of Functional Foods, 67. doi:10.1016/j.jff.2020.103823
NLM
Pinheiro JEG, Martinez CS, Moraes PZ, Stasiaki JE, Trost ME, Vassallo DV, Barbosa Junior F, Peçanha FM, Cibin FWS, Miguel M, Wiggers GA. Egg white hydrolysate prevents reproductive impairments induced by cadmium in rats [Internet]. Journal of Functional Foods. 2020 ; 67[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jff.2020.103823
Vancouver
Pinheiro JEG, Martinez CS, Moraes PZ, Stasiaki JE, Trost ME, Vassallo DV, Barbosa Junior F, Peçanha FM, Cibin FWS, Miguel M, Wiggers GA. Egg white hydrolysate prevents reproductive impairments induced by cadmium in rats [Internet]. Journal of Functional Foods. 2020 ; 67[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jff.2020.103823
Artigo de periodico-carta/editorial
CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] (2020)
Arruda, Lucas Coelho Marliére; Clave, Emmanuel; Douay, Corinne; Lima Júnior, João Rodrigues; Slavov, Svetoslav Nanev; Farias, Kelen Cristina Ribeiro Malmegrim de ; Alberdi, Antônio José; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine
Fonte: Rheumatology. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS CLONAIS, IMUNOLOGIA, CITOMEGALOVIRUS, TRANSPLANTES, CÉLULAS-TRONCO, RECEPTORES, ANTÍGENOS, VIROLOGIA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas Coelho Marliére et al. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/rheumatology/keaa001. Acesso em: 11 jun. 2024. , 2020
APA
Arruda, L. C. M., Clave, E., Douay, C., Lima Júnior, J. R., Slavov, S. N., Farias, K. C. R. M. de, et al. (2020). CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/rheumatology/keaa001
NLM
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Vancouver
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Parte de monografia/livro
Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Fonte: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 11 jun. 2024.
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico
Oral microbiota and Alzheimer’s disease: do all roads lead to Rome? (2020)
Sureda, Antoni; Daglia, Maria; Argüelles Castilla, Sandro; Sanadgol, Nima; Nabavi, Seyed Fazel; Khan, Haroon; Belwal, Tarun; Jeandet, Philippe; Marchese, Anna; Pistollato, Francesca; Forbes-Hernandez, Tamara; Battino, Maurizio; Berindan-Neagoe, Ioana; D’Onofrio, Grazia; Nabavi, Seyed Mohammad
Fonte: Pharmacological Research. Unidade: FCFRP
Assuntos: DOENÇA DE ALZHEIMER, SAÚDE BUCAL, HIGIENE BUCAL, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUREDA, Antoni et al. Oral microbiota and Alzheimer’s disease: do all roads lead to Rome?. Pharmacological Research, v. 151, p. 1-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104582. Acesso em: 11 jun. 2024.
APA
Sureda, A., Daglia, M., Argüelles Castilla, S., Sanadgol, N., Nabavi, S. F., Khan, H., et al. (2020). Oral microbiota and Alzheimer’s disease: do all roads lead to Rome? Pharmacological Research, 151, 1-15. doi:10.1016/j.phrs.2019.104582
NLM
Sureda A, Daglia M, Argüelles Castilla S, Sanadgol N, Nabavi SF, Khan H, Belwal T, Jeandet P, Marchese A, Pistollato F, Forbes-Hernandez T, Battino M, Berindan-Neagoe I, D’Onofrio G, Nabavi SM. Oral microbiota and Alzheimer’s disease: do all roads lead to Rome? [Internet]. Pharmacological Research. 2020 ; 151 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.phrs.2019.104582
Vancouver
Sureda A, Daglia M, Argüelles Castilla S, Sanadgol N, Nabavi SF, Khan H, Belwal T, Jeandet P, Marchese A, Pistollato F, Forbes-Hernandez T, Battino M, Berindan-Neagoe I, D’Onofrio G, Nabavi SM. Oral microbiota and Alzheimer’s disease: do all roads lead to Rome? [Internet]. Pharmacological Research. 2020 ; 151 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.phrs.2019.104582
Artigo de periodico
Combining sensory and texturometer parameters to characterize different type of cosmetic ingredients (2020)
Vieira, Gisely Spósito; Lavarde, Marc; Fréville, Vianney; Rocha-Filho, Pedro Alves da ; Pensé‐Lhéritier, Anne‐Marie
Fonte: International Journal of Cosmetic Science. Unidade: FCFRP
Assuntos: COSMÉTICOS, FISIOLOGIA SENSORIAL, HIGIENE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Gisely Spósito et al. Combining sensory and texturometer parameters to characterize different type of cosmetic ingredients. International Journal of Cosmetic Science, v. 42, n. 2, p. 156-166, 2020Tradução . . Disponível em: https://doi.org/10.1111/ics.12598. Acesso em: 11 jun. 2024.
APA
Vieira, G. S., Lavarde, M., Fréville, V., Rocha-Filho, P. A. da, & Pensé‐Lhéritier, A. ‐M. (2020). Combining sensory and texturometer parameters to characterize different type of cosmetic ingredients. International Journal of Cosmetic Science, 42( 2), 156-166. doi:10.1111/ics.12598
NLM
Vieira GS, Lavarde M, Fréville V, Rocha-Filho PA da, Pensé‐Lhéritier A‐M. Combining sensory and texturometer parameters to characterize different type of cosmetic ingredients [Internet]. International Journal of Cosmetic Science. 2020 ; 42( 2): 156-166.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/ics.12598
Vancouver
Vieira GS, Lavarde M, Fréville V, Rocha-Filho PA da, Pensé‐Lhéritier A‐M. Combining sensory and texturometer parameters to characterize different type of cosmetic ingredients [Internet]. International Journal of Cosmetic Science. 2020 ; 42( 2): 156-166.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/ics.12598
Artigo de periodico-carta/editorial
Antimicrobial resistance as a global public health problem: how can we address it? [Editorial] (2020)
Minarini, Luciene Andrade Da Rocha; Andrade, Leonardo Neves de ; De Gregorio, Eliana; Grosso, Filipa; Naas, Thierry; Zarrilli, Raffaele; Camargo, Ilana Lopes Baratella da Cunha
Fonte: Frontiers in Public Health. Unidades: IFSC, FCFRP
Assuntos: ENZIMAS, ANTIBIÓTICOS (RESISTÊNCIA), BIOTECNOLOGIA, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MINARINI, Luciene Andrade Da Rocha et al. Antimicrobial resistance as a global public health problem: how can we address it? [Editorial]. Frontiers in Public Health. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fpubh.2020.612844. Acesso em: 11 jun. 2024. , 2020
APA
Minarini, L. A. D. R., Andrade, L. N. de, De Gregorio, E., Grosso, F., Naas, T., Zarrilli, R., & Camargo, I. L. B. da C. (2020). Antimicrobial resistance as a global public health problem: how can we address it? [Editorial]. Frontiers in Public Health. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.3389/fpubh.2020.612844
NLM
Minarini LADR, Andrade LN de, De Gregorio E, Grosso F, Naas T, Zarrilli R, Camargo ILB da C. Antimicrobial resistance as a global public health problem: how can we address it? [Editorial] [Internet]. Frontiers in Public Health. 2020 ; No 2020 612844-1-612844-6.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fpubh.2020.612844
Vancouver
Minarini LADR, Andrade LN de, De Gregorio E, Grosso F, Naas T, Zarrilli R, Camargo ILB da C. Antimicrobial resistance as a global public health problem: how can we address it? [Editorial] [Internet]. Frontiers in Public Health. 2020 ; No 2020 612844-1-612844-6.[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/fpubh.2020.612844
Artigo de periodico
Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation (2020)
Von Borowski, Rafael Gomes; Barros, Muriel Primon de; Silva, Denise Brentan da; Lopes, Norberto Peporine ; Zimmer, Karine Rigon; Staats, Charley Christian; Oliveira, Cristiane Bernardes de; Giudice, Emmanuel; Gillet, Reynald; Macedo, Alexandre José; Gnoatto, Simone Cristina Baggio; Zimmer, Aline Rigon
Fonte: International Journal of Pharmaceutics. Unidade: FCFRP
Assuntos: BIOFILMES, PEPTÍDEOS, PIMENTA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VON BOROWSKI, Rafael Gomes et al. Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation. International Journal of Pharmaceutics, v. 574, p. 118872, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2019.118872. Acesso em: 11 jun. 2024.
APA
Von Borowski, R. G., Barros, M. P. de, Silva, D. B. da, Lopes, N. P., Zimmer, K. R., Staats, C. C., et al. (2020). Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation. International Journal of Pharmaceutics, 574, 118872. doi:10.1016/j.ijpharm.2019.118872
NLM
Von Borowski RG, Barros MP de, Silva DB da, Lopes NP, Zimmer KR, Staats CC, Oliveira CB de, Giudice E, Gillet R, Macedo AJ, Gnoatto SCB, Zimmer AR. Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation [Internet]. International Journal of Pharmaceutics. 2020 ; 574 118872.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118872
Vancouver
Von Borowski RG, Barros MP de, Silva DB da, Lopes NP, Zimmer KR, Staats CC, Oliveira CB de, Giudice E, Gillet R, Macedo AJ, Gnoatto SCB, Zimmer AR. Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation [Internet]. International Journal of Pharmaceutics. 2020 ; 574 118872.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118872
Artigo de periodico
Aspergillus fumigatus transcription factors involved in the caspofungin paradoxical effect (2020)
Fernández, Clara Isabel Valero ; Colabardini, Ana Cristina ; Chiaratto, Jéssica; Pardeshi, Lakhansing ; Silva, Patrícia Alves de Castro ; Ferreira Filho, Jaire Alves ; Silva, Lilian Pereira; Rocha, Marina Campos ; Malavazi, Iran ; Costa, Jonas Henrique ; Fill, Taícia ; Barros, Mário Henrique de ; Wong, Sarah Sze Wah ; Aimanianda, Vishukumar ; Wong, Koon Ho ; Goldman, Gustavo Henrique
Unidades: ICB, FCFRP, FMRP
Assuntos: MICROBIOLOGIA, ASPERGILLUS, CÁLCIO, MITOCÔNDRIAS, FATORES DE TRANSCRIÇÃO, ANTIFÚNGICOS, MUTAÇÃO GENÉTICA, PAREDE CELULAR VEGETAL, RNA POLIMERASES, ANTIMICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNÁNDEZ, Clara Isabel Valero et al. Aspergillus fumigatus transcription factors involved in the caspofungin paradoxical effect. 2020Tradução . . Disponível em: https://doi.org/10.1128/mBio.00816-20. Acesso em: 11 jun. 2024.
APA
Fernández, C. I. V., Colabardini, A. C., Chiaratto, J., Pardeshi, L., Silva, P. A. de C., Ferreira Filho, J. A., et al. (2020). Aspergillus fumigatus transcription factors involved in the caspofungin paradoxical effect. doi:10.1128/mBio.00816-20
NLM
Fernández CIV, Colabardini AC, Chiaratto J, Pardeshi L, Silva PA de C, Ferreira Filho JA, Silva LP, Rocha MC, Malavazi I, Costa JH, Fill T, Barros MH de, Wong SSW, Aimanianda V, Wong KH, Goldman GH. Aspergillus fumigatus transcription factors involved in the caspofungin paradoxical effect [Internet]. 2020 ;[citado 2024 jun. 11 ] Available from: https://doi.org/10.1128/mBio.00816-20
Vancouver
Fernández CIV, Colabardini AC, Chiaratto J, Pardeshi L, Silva PA de C, Ferreira Filho JA, Silva LP, Rocha MC, Malavazi I, Costa JH, Fill T, Barros MH de, Wong SSW, Aimanianda V, Wong KH, Goldman GH. Aspergillus fumigatus transcription factors involved in the caspofungin paradoxical effect [Internet]. 2020 ;[citado 2024 jun. 11 ] Available from: https://doi.org/10.1128/mBio.00816-20
Monografia/livro-ed/org
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de (Editor) ; Rodrigues, Maria Carolina de Oliveira (Editor); Toubert, Antoine (Editor); Bancel, Dominique Farge (Editor)
Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. . Lausanne: Frontiers Media. Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 11 jun. 2024. , 2020
APA
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2024 jun. 11 ] Available from: https://doi.org/10.3389/978-2-88963-472-9

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos